Here’s why I think BetaShares Asia Technology Tigers ETF (ASX:ASIA) and this ETF are among the best on offer on the ASX right now…
The post Here are 2 of the best ETFs you can buy today appeared first on Motley Fool Australia. –
Exchange traded funds (ETFs) certainly are becoming increasingly popular with Australian investors.
Last year the total funds invested into ETFs in Australia reached $50 billion. Incredibly, this number is expected to double to $100 billion by 2022.
I don’t find this overly surprising considering the advantages that they offer investors.
Investing globally or into certain themes has been a very challenging endeavour for investors in the past. But now, thanks to ETFs, it is as simple as opening up a brokerage account.
Given the growing popularity of ETFs, you won’t be surprised to learn that there is an increasing collection of funds for investors to choose from.
But with so much choice, it can be hard to decide which ones to buy. To help readers narrow things down, I have picked out two ETFs which I think are among the best on offer today.
They are as follows:
BetaShares Asia Technology Tigers ETF (ASX: ASIA)
I think the BetaShares Asia Technology Tigers ETF would be a great option for investors. This ETF tracks the performance of the 50 largest technology and ecommerce companies that have their main area of business in Asia, excluding Japan. This includes giants such as Alibaba, Samsung, and Tencent Holdings. As these and the other companies in the ETF are among the fastest growing in the region and revolutionising the lives of billions of people, I believe it could provide strong returns over the 2020s.
iShares Global Healthcare ETF (ASX: IXJ)
Another ETF to consider buying is the iShares Global Healthcare ETF. This exchange traded fund gives investors access to many of the biggest and brightest healthcare companies in the world. This includes CSL Ltd (ASX: CSL), Johnson & Johnson, Novartis, and Ramsay Health Care Limited (ASX: RHC). Due to the positive outlook for the healthcare sector over the next couple of decades due to ageing populations and increased chronic disease, I believe it could provide strong returns for investors.
Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
*Returns as of 6/8/2020
- Where to invest $10,000 into ASX shares right now
- 3 ASX growth ETFs to add to your portfolio
- Buy BetaShares NASDAQ 100 ETF (ASX:NDQ) and these outstanding ETFs today
- 2 ETFs for easy investing and strong returns
- Where to invest $20,000 into ASX shares right now
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended BetaShares Asia Technology Tigers ETF. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.